Coronavirus Protein Structures

Deciphering and comparing the proteins of different coronaviruses forms a basis for understanding SARS-CoV-2 evolution and virus-receptor interactions. This feed follows studies analyzing the structures of coronavirus proteins, thereby revealing potential drug target sites.

July 17, 2020
Review
Open Access

COVID-19 vaccine development and a potential nanomaterial path forward

Nature Nanotechnology
Matthew D ShinNicole F Steinmetz
July 20, 2020
Preprint
Open Access

Probing the dynamic structure-function and structure-free energy relationships of the corona virus main protease with Biodynamics theory

BioRxiv : the Preprint Server for Biology
H. WanRobert Alan Pearlstein
July 20, 2020
Preprint
Open Access

Cryo-electron Microscopy and Exploratory Antisense Targeting of the 28-kDa Frameshift Stimulation Element from the SARS-CoV-2 RNA Genome

BioRxiv : the Preprint Server for Biology
Kaiming ZhangRhiju Das
June 25, 2020
Preprint
Open Access

Molecular evolution of SARS-CoV-2 structural genes: evidence of positive selection in spike glycoprotein

BioRxiv : the Preprint Server for Biology
X.-Y. ZhanY. He
July 16, 2020
Open Access

Polymorphic Forms of Valinomycin Investigated by NMR Crystallography

International Journal of Molecular Sciences
Jiří Czernek, Jiří Brus
July 29, 2020
Preprint
Open Access

Allosteric inhibition of the SARS-CoV-2 main protease - insights from mass spectrometry-based assays

BioRxiv : the Preprint Server for Biology
T. J. El-BabaCarol V Robinson
July 10, 2020
Preprint
Open Access

Stabilizing the Closed SARS-CoV-2 Spike Trimer

BioRxiv : the Preprint Server for Biology
July 18, 2020
Preprint
Open Access

Structural basis for the inhibition of the papain-like protease of SARS-CoV-2 by small molecules

BioRxiv : the Preprint Server for Biology
Zhen F FuHao Huang
August 6, 2020
Open Access

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) - A drug repurposing study

Heliyon
Jamshaid AhmadMaryam Mushtaq
July 10, 2020
Open Access

A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Cell
Lianpan DaiGeorge F Gao
July 4, 2020
Open Access

Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products

Interdisciplinary Sciences, Computational Life Sciences
Abbas KhanDong-Qing Wei
July 19, 2020
Open Access

Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein

Nature Communications
Xiaoyi FanXinzheng Zhang
July 9, 2020
Open Access

Citizen Scientists Create an Exascale Computer to Combat COVID-19

BioRxiv : the Preprint Server for Biology
Maxwell I ZimmermanGregory R Bowman
June 30, 2020
Preprint
Open Access

Conformational dynamics of SARS-CoV-2 trimeric spike glycoprotein in complex with receptor ACE2 revealed by cryo-EM

BioRxiv : the Preprint Server for Biology
C. XuYao Cong
July 31, 2020
Open Access

Crystal structure of SARS-CoV-2 nsp10/nsp16 2'-O-methylase and its implication on antiviral drug design

Signal Transduction and Targeted Therapy
Sheng LinGuangwen Lu

Sign up to follow this feed and discover related papers.

Related Feeds

AI-driven COVID-19 Management

Artificial intelligence (AI) offers a powerful new tool that could potentially be instrumental in controling and managing the SARS-CoV-2 virus. The papers in this feed report on the applications of AI to the current pandemic, which may be able to predict the location of the next outbreak, or facilitate new drug design.

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

COVID-19 Cardiovascular Complications

Growing evidence shows that COVID-19 can result in serious complications affecting the cardiovascular system, including dysrhythmias, myocarditis, acute myocardial infarction, and heart failure. This feed follows studies investigating the effects of SARS-CoV-2 infection on the heart.

COVID-19 Clinical Diagnosis

COVID-19 patients typically present with high fever and a persistent cough. This feed focuses on clinical diagnosis, including RT-PCR testing for the presence of SARS-CoV-2 and radiographic assessment of lungs.

COVID-19 Clinical Management

While most COVID-19 infections cause only mild to moderate symptoms, severely affected patients, such as those presenting with pneumonia, ARDS or septic shock, require hospitalization. This feed focuses on clinical management of patients using oxygen therapy, ventilation, and other treatment strategies, and covers some medical case reports.

COVID-19 Comorbidities

COVID-19 represents a particular challenge to people with serious chronic medical conditions such as diabetes, hypertension, cardiovascular disease, and chronic lung disease. Research into the intersection between comorbidities and COVID-19 is focusing on risks and treatment outcomes for these patients.

COVID-19 Complications

A growing number of complications associated with COVID-19 has been identified. This feed focuses primarily on cardiovascular and respiratory manifestations in severely ill patients.

COVID-19 Covalescent Plasma Therapy

Convalescent plasma therapy, where passive polyclonal antibody obtained from recovered patients are used to provide immediate immunity, has been tested in respiratory infections such as the 2009-2010 H1N1 influenza virus pandemic and the 2003 SARS-CoV-1 epidemic. This feed follows ongoing research efforts and clinical trials exploring covalescent plasma therapy as a potential treatment strategy for COVID-19.

COVID-19 Epidemiology and Demography

Epidemiological studies play a crucial role in understanding and managing the progression of COVID-19. Research followed in this feed includes studies of transmission dynamics and the change of the basic reproductive number (R) as new pubic health measures take effect.

COVID-19 Immune Response

Understanding the innate and acquired immune response to SARS-CoV-2 is essential for development of COVID-19 therapeutic treatment and design of prophylactic vaccines. This feed surfaces immunological studies, including studies into the cytokine storm that has been observed in severely ill patients.

© 2020 Meta ULC. All rights reserved
/feed-previews/coronavirus-protein-structures/ad647107-5e8a-4be4-ab18-a42f07747299